Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Citric acid/lactic acid/potassium bitartrate - Evofem Biosciences/Rush University

Next Previous
Drug Profile

Citric acid/lactic acid/potassium bitartrate - Evofem Biosciences/Rush University

Alternative Names: Acidform; Amphora; Amphora contraceptive vaginal gel; EVO 100; EVO-200; Femidence; Multipurpose Vaginal pH Regulator™; MVP-R; Phexxi; PHEXXI™ vaginal gel 0.4%; PHEXXI™ vaginal gel 1%; PHEXXI™ vaginal gel 1.8%; VPRTM

Latest Information Update: 23 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Rush University
  • Developer Evofem Biosciences
  • Class Anti-infectives; Antibacterials; Contraceptives; Electrolytes; Esters; Hydroxy acids; Lactates; Potassium compounds; Tricarboxylic acids
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Pregnancy
  • Preregistration Sexually transmitted infections
  • Phase III Chlamydial infections; Gonorrhoea
  • No development reported Bacterial vaginosis

Most Recent Events

  • 20 Mar 2025 Windtree Therapeutics enters a license and supply agreement with Evofem Biosciences for citric acid/Lactic acid/potassium bitartarate
  • 14 Nov 2024 Pharma 1 announces intention to submit for UAE regulatory application for Citric acid/lactic acid/potassium bitartrate in end of 2024
  • 23 Jul 2024 Citric acid/lactic acid/potassium bitartrate licensed to Pharma 1 Drug Store in Middle East, including the United Arab Emirates (UAE), Kuwait, Saudi Arabia, Qatar

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top